PKM and cardiac hypertrophy: Tang et al. used the small molecule activator TEPP-46 to convert PKM2 dimers to enzymatically active PKM2 tetramers and found that this was able to reduce TCA-induced metabolic impairments and rescue the metabolic dysfunction and cardiac hypertrophy induced by knockdown of Jmjd4.